The global dermatological drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various diseases related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatological, are products that are applied topically on the skin. These products are used to treat skin conditions and are also employed to prevent certain skin disorders. Furthermore, dermatological is also used for routine skin care to maintain one’s skin. However, some of the dermatological are systemic preparations, which are used in patients who are not responsive to topical medications. Moreover, these preparations are used to treat various skin conditions such as acne, dermatitis, and psoriasis. A large number of drugs have been approved by the FDA and other regulatory bodies of different nations for several skin conditions and disorders. 

The major factors that are expected to boost the market include a rise in demand for topical dermatological drugs such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne. Furthermore, the rise in awareness about skin diseases, high demand for rapid diagnosis, and surge in the incidence of skin cancer and other skin disorders are some factors that are anticipated to accelerate the growth of the market. Moreover, the development of innovative products and an increase in the number of mergers & acquisitions by key vendors are expected to provide numerous opportunities for the growth of the market during the forecast period. Furthermore, a rise in awareness related to the use of topical ointments for the management and treatment of psoriasis is another major factor that fuels the growth of the market during the forecast period. However, lack of awareness about the drugs and stringent government regulations restrains the growth of the global dermatology drugs market.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Disease

o By Type 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Novartis International AG, AbbVie Inc., and Sanofi S.A., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Dermatological Drugs Market Report by Segment

By Disease

    • Acne

    • Dermatitis

    • Psoriasis

    • Skin Cancer

    • Rosacea

    • Alopecia

    • Others

By Type

    • Prescription-Based

    • OTC Drugs

Global Dermatological Drugs Market by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa